Kenneth Buckfire
Chief Executive Officer @ Miller Buckfire
New York, United States
Kenneth Buckfire is a Series A investor at Miller Buckfire in New York focused on Medical and Health Care. Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Kenneth Buckfire invests in
Stages Kenneth Buckfire invests in
Countries Kenneth Buckfire invests in
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
- Life Science 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. | $10.4M / Series A / Jun 03, 2021 |
Co-Investors
About Miller Buckfire
Miller Buckfire is an internationally recognized investment bank focused on helping clients address complex transformational issues.
Miller Buckfire Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Kenneth Buckfire
Chief Executive Officer
|
|||
|
Durc Savini
Managing Director
|
|||
|
Harvey Golub
Chairman
|
|||
|
Michael Wildish
Managing Director
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Kenneth Buckfire invest in?
Kenneth Buckfire invests primarily in Medical, Health Care and Life Science startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Kenneth Buckfire last invest?
The most recent investment recorded for Kenneth Buckfire closed in Jun 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!